New FDA Inspection 483s: Insights on Stem Cell Clinic & Cell Surgical Network
Two new FDA inspection reports called 483s provide fresh insights on a stem cell clinic, the network of clinics that it belongs to, and adverse events in patients. These reports detail issues the FDA found at the stem cell clinic California Stem Cell Treatment Center and its parent chain of clinics, Cell Surgical Network. The […]
New FDA Inspection 483s: Insights on Stem Cell Clinic & Cell Surgical Network Read More »